We investigated the frequency and clinical significance of loss of het
erozygosity (LOH) at the APC, MCC, and DCC tumor suppressor gene loci
in 108 cases of resected non-small cell lung cancer (NSCLC). LOH at th
e APC/MCC gene cluster at chromosome 5q21 occurred frequently; it affe
cted 29% of informative NSCLC cases and correlated with a significantl
y worse survival (P < 0.01). Furthermore, in the subtype most frequent
ly affected (SCC), LOH at 5q not only correlated with a worse survival
but also tumor involvement of the mediastinal and/or hilar nodes. In
contrast, LOH at the DCC locus at chromosome 18q was far less frequent
, occurring in 14% of NSCLC cases, and it was not associated with adva
nced stage or prognosis. These data suggest that LOH at 5q has a role
in determining tumor progression and survival in NSCLC, and may prove
to be a clinically useful prognostic indicator.